---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-037114"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2026-09-18T20:06:23+00:00"
generated_at: "2026-09-18T20:07:08.969277+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Grace Therapeutics annual meeting: directors re-elected, say-on-pay approved

## Summary
- Annual meeting held Sept 17, 2026; 9,973,325 shares present (61.28% of 16,274,026 outstanding).
- All five director nominees elected: Kavuru, Davis, Kohli, Kottayil, Neugeboren, each with ~6.0M votes for.
- Say-on-pay approved: 5,740,999 for vs 222,775 against (93% support excluding broker non-votes).
- KPMG LLP ratified as auditor for FY2027: 9,878,292 for, 63,381 against.
- Shareholders favor 1-year frequency for say-on-pay (5,772,652 votes); board adopts annual vote.

## SEC filing metadata
- accession: 0001140361-26-037114
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2026-09-18T20:06:23+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/0001140361-26-037114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/ef20082416_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-037114
- JSON: https://secwatch.observer/filing/0001140361-26-037114.json
- Plain text: https://secwatch.observer/filing/0001140361-26-037114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.